Novel SonaSurgery Treatment, Using "Sound Based Therapy," Will Be Introduced

Charlotte, N.C., January 7, 2014 -- SonaCare Medical, LLC (SonaCare Medical), a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, will present at the upcoming J.P. Morgan Healthcare Conference being held in San Francisco, CA.  Michael Klein, Chief Executive Officer of SonaCare Medical, will present on Tuesday, January 14, 2014 at 4:30 p.m. PST.

Vincent Prajka Brings Significant Financial, Operational and Administrative Expertise as the Company Nears U.S. Commercialization of its High Intensity Focused Ultrasound (HIFU) Treatment Platform

Charlotte, N.C. - September 4, 2013 -- SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced today that Vincent (Vinny) Prajka has joined as Chief Financial Officer.  

Results demonstrate that MRI-US registration and fusion software can inform the planning of new tissue preserving treatments for prostate cancer using the Sonablate® 500 system

CHARLOTTE, N.C. and LONDON, Thursday, July 25, 2013 – Study results published in the current issue of British Journal of Urology International (10.1111/bju.12223) demonstrate that new software to register and fuse information from magnetic resonance imaging (MRI) and ultrasound (US) images enables intraoperative visualization of tumors, not ordinarily seen in a US image. This technology has the potential to support new tissue-preserving treatments for prostate cancer, such as focal therapy.

With Successful Launch of Sonatherm® HIFU Surgical Ablation System at AUA, SonaCare Medical Delivers on the Promise of Image Guided Minimally Invasive Technology

SAN DIEGO, Thursday, May 23, 2013 - The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108th Annual Meeting of the American Urological Association (AUA), in San Diego.  According to SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, the need for image-guided technologies to better identify and localize disease, and for urologists to consider minimally invasive ablative treatments, was addressed in the Opening Session, the Dr. W. Whitmore Memorial Lecture, and multiple sessions throughout the AUA meeting.

UCL's Mark Emberton, MD, to Direct Premier Training Center for the Use of Advanced Imaging Capabilities to Localize Cancer and Deliver HIFU Treatment Using Tissue Preserving Techniques

CHARLOTTE, N.C., Thursday, May 2, 2013 - SonaCare Medical, a global leader in minimally invasive HIFU technologies, announced today that it has partnered with University College London (UCL) to create a HIFU Center of Excellence. The Center of Excellence will provide physician training and proctoring along with clinical studies, patient satisfaction research and advanced technology development associated with two innovative HIFU systems: the Sonatherm® laparoscopic HIFU surgical ablation system and the Sonablate® 500 transrectal HIFU surgical ablation system.

HIFU company

Latest News

17 May 2018

SonaCare Medical congratulates Naren Sanghvi on his receipt of The William and Francis Fry Honorary Fellowship for Contributions to Therapeutic Ultrasound

10 April 2018

Over 120 urologists gather at Imperial College London to learn new diagnostic techniques and minimally invasive focal approaches for treating prostate cancer.